Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Evoke Pharma, Inc. - Common Stock (NQ:EVOK)

5.180 +0.110 (+2.17%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 14,334
Open 5.010
Bid (Size) 5.060 (2)
Ask (Size) 5.350 (1)
Prev. Close 5.070
Today's Range 5.010 - 5.220
52wk Range 1.940 - 12.32
Shares Outstanding 3,343,070
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
12 Health Care Stocks Moving In Friday's After-Market Session
 
Via Benzinga
Wondering what's happening in today's pre-market session?
As we await the opening of the US market on Friday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment. 
Via Chartmill

Performance

YTD
+15.9%
+15.9%
1 Month
-13.1%
-13.1%
3 Month
+75.9%
+75.9%
6 Month
+48.5%
+48.5%
1 Year
+22.7%
+22.7%

More News

Read More
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Thursday's after hours session: top gainers and losers
Via Chartmill
These stocks that are showing activity before the opening bell on Thursday.
Via Chartmill
5 Healthcare Stocks On Fire This Week
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Evoke Pharma Posts 47 Percent Q2 Growth
Via The Motley Fool
Evoke Pharma Stock Skyrockets On Patent For Nasal Spray That Eases Stomach Delays; Retail Bulls Pile In
Via Stocktwits
Topics Intellectual Property
Crude Oil Moves Higher; RxSight Shares Plunge
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Evoke Pharma (EVOK) Shares Skyrocket On New Patent: What's Going On?
Via Benzinga
Topics Intellectual Property
Dow Jumps 200 Points; US Wholesale Inventories Fall 0.3% In May
Via Benzinga
Topics Stocks
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Earnings Scheduled For March 13, 2025
Via Benzinga
Why VF Corp Shares Are Trading Higher By Around 21%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
S&P 500 Moves Higher; Philips Shares Plunge After Q3 Earnings
Via Benzinga
Topics Stocks
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Crude Oil Tumbles Over 5%; Autonomix Medical Shares Spike Higher
Via Benzinga
Dow Jumps Over 300 Points; ON Semiconductor Earnings Top Views
Via Benzinga
Topics Stocks
Evoke Pharma Stock Is Soaring Monday: What's Going On?
Via Benzinga

Frequently Asked Questions

Is Evoke Pharma, Inc. - Common Stock publicly traded?
Yes, Evoke Pharma, Inc. - Common Stock is publicly traded.
What exchange does Evoke Pharma, Inc. - Common Stock trade on?
Evoke Pharma, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Evoke Pharma, Inc. - Common Stock?
The ticker symbol for Evoke Pharma, Inc. - Common Stock is EVOK on the Nasdaq Stock Market
What is the current price of Evoke Pharma, Inc. - Common Stock?
The current price of Evoke Pharma, Inc. - Common Stock is 5.180
When was Evoke Pharma, Inc. - Common Stock last traded?
The last trade of Evoke Pharma, Inc. - Common Stock was at 09/16/25 04:00 PM ET
What is the market capitalization of Evoke Pharma, Inc. - Common Stock?
The market capitalization of Evoke Pharma, Inc. - Common Stock is 17.32M
How many shares of Evoke Pharma, Inc. - Common Stock are outstanding?
Evoke Pharma, Inc. - Common Stock has 17M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.